GHRS - Latest News
GH Research PLC (GHRS), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $2.02B. Beta to the broader market is 1.29.
The article list below shows the most recent GHRS headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent GHRS Headlines
GH Research Reports Second Quarter 2026 Financial Results and Provides Business Update
globenewswire.com - Aug 6, 2026
Alignment with FDA on CMC and device plans for Phase 3 Successfully completed GH001-HV-106 and GH001-HV-109 Phase 1 trials Further strengthening of U
Why Is GH Research Stock Trading Higher on Thursday?
benzinga.com - Jul 16, 2026
GH Research PLC (NASDAQ:GHRS) and Definium Therapeutics Inc. (NASDAQ:DFTX) stocks are trading higher in response to Eli Lilly and Co.
CleanSpark shares surge after company secures $6.6B data center lease agreement
proactiveinvestors.com - Jul 14, 2026
CleanSpark Inc (NASDAQ:CLSK) shares surged more than 12% after the company announced a 20-year lease agreement for its Sandersville, Georgia data cent
Tower Semiconductor shares jump as company announces Japan expansion to boost silicon photonics capacity
proactiveinvestors.com - Jul 14, 2026
Tower Semiconductor (NASDAQ:TSEM) shares rose 13% on Tuesday after the company announced a strategic expansion of its silicon photonics, silicon germa
Psychedelics guidance from the FDA set to benefit developers, including AtaiBeckley, Jefferies says
proactiveinvestors.com - Jul 13, 2026
The US Food and Drug Administration's finalized guidance on psychedelic drug development signals the agency remains receptive to helping developers na
How News Affects GHRS Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track GHRS's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked GHRS news questions
- What is the latest GHRS news headline?
- The most recent GHRS headline (Aug 6, 2026) is "GH Research Reports Second Quarter 2026 Financial Results and Provides Business Update". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the GHRS news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What GHRS news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual GHRS options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.